Noriaki Sunaga

Multiple Oncogenic Changes (<i>K-RASV12</i>, p53 Knockdown,<i>Mutant EGFRs, p16</i>Bypass, Telomerase) Are Not Sufficient to Confer a Full Malignant Phenotype on Human Bronchial Epithelial Cells

Mitsuo Sato, Melville B. Vaughan, Luc Girard et al. · Cancer Research · 2006 · 266 citations

Medicine, Cell Biology, Oncology +17

Prognostic significance of L-type amino acid transporter 1 expression in resectable stage I–III nonsmall cell lung cancer

Kyoichi Kaira, Noboru Oriuchi, Hisao Imai et al. · British Journal of Cancer · 2008 · 214 citations · Full text

Medicine, Cancer Biology, Oncology +15

Metabolic activity by 18F–FDG-PET/CT is predictive of early response after nivolumab in previously treated NSCLC

Kyoichi Kaira, Tetsuya Higuchi, Ichiro Naruse et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2017 · 191 citations

Medicine, Nuclear Medicine, Oncology +15

Knockdown of Oncogenic KRAS in Non–Small Cell Lung Cancers Suppresses Tumor Growth and Sensitizes Tumor Cells to Targeted Therapy

Noriaki Sunaga, David S. Shames, Luc Girard et al. · Molecular Cancer Therapeutics · 2011 · 183 citations · Full text

Medicine, Molecular Biology, Oncology +17

Different Roles for Caveolin-1 in the Development of Non-Small Cell Lung Cancer <b> <i>versus</i> </b> Small Cell Lung Cancer

Noriaki Sunaga, Kuniharu Miyajima, Makoto Suzuki et al. · Cancer Research · 2004 · 178 citations

Medicine, Cell Biology, Oncology +14